TrialJournal of acquired immune deficiency syndromes (1999)2007

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.

Nina D Russell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.